SecBot SecBot
3 ·Filed Jun 9, 2026

VRXA

Veraxa Biotech Holding AG
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001438327-26-000003
Form 3 — initial insider ownership statement
Actionable Insight • Neutral

This Form 3 is a routine disclosure with no trading activity or corporate event. Monitor for future insider transactions (Form 4) or material corporate developments (e.g., clinical trial results, financing) for trading signals.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
VRXA ▼ -91.06% at T+60d
NEUTRAL call -91.06% · α vs SPY -97.92% · entry $17.12 → $1.53
Entry = T+0 close
Jun 9, 2026
via day close
T+1d
+44.84%
call +44.84% · α +43.14%
$24.79
settled 5mo ago
T+5d
-65.76%
call -65.76% · α -67.90%
$5.86
settled 4mo ago
T+20d
-85.51%
call -85.51% · α -89.40%
$2.48
settled 4mo ago
T+60d
-91.06%
call -91.06% · α -97.92%
$1.53
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Warren Hosseinion filed a Form 3 initial statement of beneficial ownership with the SEC, reporting 700,000 ordinary shares of Veraxa Biotech Holding AG held directly. This is a routine insider filing required upon becoming a reporting person and does not convey any material change in the company's operations or financial condition.

Key Facts

  • Warren Hosseinion filed a Form 3 initial statement of beneficial ownership on 2026-06-09.
  • Hosseinion directly owns 700,000 ordinary shares of Veraxa Biotech Holding AG.
  • No derivative securities or indirect ownership reported.
  • Filing is a standard SEC requirement for new reporting persons; no transaction occurred.

Financial Impact

No financial impact; filing is a routine ownership disclosure with no transaction or material change.

Risk Factors

  • No material risks identified from this filing alone.

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001438327-26-000003
Document: 0001438327-26-000003-index.html0001438327-26-000003
Document: 0001438327-26-000003.txt0001438327-26-000003
16 reports for VRXA
Performance horizon
100% Hit rate @ T+20 5 of 5 directional calls Went positive at some point 5 of 5 best @ T+60▲ +71.84%Jun 16, 2026
Filters
Rows
Reports for VRXA — sortable, filterable
TypeNow
Oct 15, 2026
12d ago
6-K
NEUTRAL ★ 4/10
$1.11awaiting T+20—$0.9997 (−9.94%)
Sep 4, 2026
7w ago
6-K
NEUTRAL ★ 3/10
$1.76 $1.13▼ −35.80%▼ −36.40%$0.9997 (−43.20%)
Sep 4, 2026
7w ago
Press Release
NEUTRAL ★ 2/10
$1.76 $1.13▼ −35.80%▼ −36.40%$0.9997 (−43.20%)
Aug 24, 2026
9w ago
6-K
NEUTRAL ★ 3/10
$1.78 $1.46▼ −17.98%▼ −17.99%$0.9997 (−43.84%)
Aug 10, 2026
11w ago
EFFECT
BEARISH ★ 6/10
$1.85 $1.60▲ +13.51%▲ +12.60%$0.9997 (+45.96%)
Aug 7, 2026
11w ago
EFFECT
BEARISH ★ 6/10
$1.99 $1.76▲ +11.56%▲ +11.16%$0.9997 (+49.76%)
Jul 31, 2026
12w ago
F-1
BEARISH ★ 6/10
$1.83 $1.35▲ +26.23%▲ +27.47%$0.9997 (+45.37%)
Jul 31, 2026
12w ago
F-1
BEARISH ★ 6/10
$1.83 $1.35▲ +26.23%▲ +27.47%$0.9997 (+45.37%)
Jul 27, 2026
13w ago
6-K
NEUTRAL ★ 3/10
$1.98 $1.73▼ −12.63%▼ −16.01%$0.9997 (−49.51%)
Jul 27, 2026
13w ago
6-K
NEUTRAL ★ 4/10
$2.01 $1.78▼ −11.44%▼ −14.74%$0.9997 (−50.26%)
Showing 10 of 16

US Market Status

Market Closed — Opens Wed (16h 34m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 9, 2026